Michael Raphael Tadross

Our goal is to bridge the gap between the study of brain as a computational device and the search for novel neuropathological treatments. We develop technologies to manipulate molecules, cells, and synapses in the brain, and deploy these reagents in mouse models of disease.

Selected Grants

Neurobiology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institute of Neurological Disorders and Stroke · 2024 - 2029

ElectroGLuE

FellowshipPrincipal Investigator · Awarded by Burroughs Wellcome Fund · 2025 - 2027

The role of dystrophin in synapse development.

ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2024 - 2027

DART.3-Revolutionizing Neuropsychiatric Treatment through Noninvasive, Programmable Cell-Type-Specific Neuropharmacology

ResearchPrincipal Investigator · Awarded by National Institute of Mental Health · 2024 - 2027

University Training Program in Biomolecular and Tissue Engineering

Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 1994 - 2027

Unmasking neuromodulatory control of locomotion

ResearchPrincipal Investigator · Awarded by Washington University in St. Louis · 2024 - 2027

Neuroactive steroids as novel psychiatric treatments: mechanistic studies

ResearchPrincipal Investigator · Awarded by Washington University in St. Louis · 2021 - 2027

High-resolution measurement of natural stimuli and ethologically relevant behavior as platform for understanding the nervous system

ResearchCo-Principal Investigator · Awarded by National Institute on Drug Abuse · 2024 - 2027

Michael Raphael Tadross

Research Interests

Selected Grants

Neurobiology Training Program

ElectroGLuE

The role of dystrophin in synapse development.

DART.3-Revolutionizing Neuropsychiatric Treatment through Noninvasive, Programmable Cell-Type-Specific Neuropharmacology

University Training Program in Biomolecular and Tissue Engineering

Unmasking neuromodulatory control of locomotion

Neuroactive steroids as novel psychiatric treatments: mechanistic studies

High-resolution measurement of natural stimuli and ethologically relevant behavior as platform for understanding the nervous system

CB1 receptors mediate metaplasticity in the cerebellar circuit

CIRCUIT MECHANISMS FOR DOPAMINE NEURON VULNERABILITY AND RESILIENCE IN PD - Extension

Parvalbumin interneurons regulate nucleus accumbens synapses and behavior

Interrogating the cholinergic basis of opioid reinforcement with subcellular precision

GRIP Display NCBioTech

Combating obesity via cell-specific pharmacology of dopamine neurons

Evaluating cell type-specific non-dopaminergics as a Parkinson's treatment paradigm

Striatal Microcircuit Drivers of Adaptive Learning in Habit Formation

Receptive field coordination across mosaics of diverse retinal ganglion cell types in the mammalian retina

DART2.0: comprehensive cell type-specific behavioral neuropharmacology

Significance of excitatory and inhibitory synaptic integration by interneurons for local circuit dynamics and behavior